Business Segments QuidelOrtho Corporation
Equities
QDEL
US2197981051
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.84 USD | +5.04% |
|
+8.84% | -62.04% |
| 05-07 | UBS Adjusts Price Target on QuidelOrtho to $12 From $17, Maintains Neutral Rating | MT |
| 05-07 | Jefferies Downgrades QuidelOrtho to Hold From Buy, Adjusts Price Target to $12.50 From $35 | MT |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Medical Testing, Analyzing, and Diagnostic Equipment | ||||||||||
Diagnostic Kits / Equipment | 1.7B | 3.27B | 3B | 2.78B | 2.73B | |||||
Total Assets | 2.43B | 8.86B | 8.56B | 6.42B | 5.77B | |||||
Interest Expense | -5.71M | -76.6M | -182M | -192M | -188M | |||||
Income Tax Expense | 196M | 187M | -19M | -79.5M | 24.1M | |||||
CAPEX | -293M | -141M | -209M | -195M | -188M | |||||
EBT | 900M | 736M | -29.1M | -2.13B | -1.11B | |||||
Gross Profit | 1.27B | - | - | - | - | |||||
D&A | 53.38M | 283M | 457M | 451M | 438M | |||||
Operating Income | 906M | 844M | 139M | -1.96B | -919M | |||||
Net Income | 704M | 549M | -10.1M | -2.05B | -1.13B |
Geographical Revenue Distribution History
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
North America | - | 2.54B | 1.88B | 1.62B | 1.49B | |||||
EBITDA | - | 1.61B | 949M | 892M | 807M | |||||
EMEA | - | 207M | 327M | 336M | 361M | |||||
EBITDA | - | 31.7M | 58.3M | 46.5M | 82.6M | |||||
China | - | 220M | 310M | 325M | 335M | |||||
EBITDA | - | 104M | 129M | 130M | 141M | |||||
JPAC | - | - | - | - | 293M | |||||
EBITDA | - | - | - | - | 73.2M | |||||
Latin America | - | - | - | - | 253M | |||||
EBITDA | - | - | - | - | 78.4M | |||||
Other | - | 303M | 483M | 502M | - | |||||
EBITDA | - | 92.7M | 116M | 134M | - | |||||
EBITDA | - | - | -530M | -660M | -585M | |||||
Foreign | 283M | - | - | - | - | |||||
Total Assets | 2.07M | 356M | 419M | 432M | 529M | |||||
EBT | - | 63.8M | 135M | 35.6M | -584M | |||||
United States | 1.42B | - | - | - | - | |||||
Total Assets | 347M | 983M | 1.02B | 948M | 829M | |||||
EBT | - | 672M | -164M | -2.17B | -524M |
- Stock Market
- Equities
- QDEL Stock
- Financials QuidelOrtho Corporation
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition